These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

47 related articles for article (PubMed ID: 8963772)

  • 21. Decay-accelerating factor (DAF/CD55) is a functional active element of the LPS receptor complex.
    Heine H; Ulmer AJ; El-Samalouti VT; Lentschat A; Hamann L
    J Endotoxin Res; 2001; 7(3):227-31. PubMed ID: 11581575
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Decay accelerating factor (CD55): a target for cancer vaccines?
    Spendlove I; Li L; Carmichael J; Durrant LG
    Cancer Res; 1999 May; 59(10):2282-6. PubMed ID: 10344729
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Complement and complement regulatory proteins in human tears.
    Willcox MD; Morris CA; Thakur A; Sack RA; Wickson J; Boey W
    Invest Ophthalmol Vis Sci; 1997 Jan; 38(1):1-8. PubMed ID: 9008624
    [TBL] [Abstract][Full Text] [Related]  

  • 24. mRNA expression of minichromosome maintenance 2 in colonic adenoma and adenocarcinoma.
    Wang Y; Li Y; Zhang WY; Xia QJ; Li HG; Wang R; Yang L; Sun XF; Zhou ZG
    Eur J Cancer Prev; 2009 Feb; 18(1):40-5. PubMed ID: 19077563
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Co-expression of alpha(1,3)galactosyltransferase and Bacillus thuringiensis PIPLC enhances hyperacute rejection of tumor cells.
    Hellrung DJ; Kisselev S; Link CJ
    Cancer Immunol Immunother; 2007 Jan; 56(1):25-34. PubMed ID: 16612594
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Impaired expression of endometrial differentiation markers and complement regulatory proteins in patients with recurrent pregnancy loss associated with antiphospholipid syndrome.
    Francis J; Rai R; Sebire NJ; El-Gaddal S; Fernandes MS; Jindal P; Lokugamage A; Regan L; Brosens JJ
    Mol Hum Reprod; 2006 Jul; 12(7):435-42. PubMed ID: 16735457
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Identification of a human anti-CD55 single-chain Fv by subtractive panning of a phage library using tumor and nontumor cell lines.
    Ridgway JB; Ng E; Kern JA; Lee J; Brush J; Goddard A; Carter P
    Cancer Res; 1999 Jun; 59(11):2718-23. PubMed ID: 10363997
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Induction of endothelial cell decay-accelerating factor by vascular endothelial growth factor: a mechanism for cytoprotection against complement-mediated injury during inflammatory angiogenesis.
    Mason JC; Lidington EA; Yarwood H; Lublin DM; Haskard DO
    Arthritis Rheum; 2001 Jan; 44(1):138-50. PubMed ID: 11212152
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Carcinoembryonic antigen, CEA, in colorectal cancer. An insensitive marker which may be excluded from follow-ups].
    Wählby L
    Lakartidningen; 1997 Apr; 94(18):1716-8. PubMed ID: 9182180
    [No Abstract]   [Full Text] [Related]  

  • 30. CD55 is over-expressed in the tumour environment.
    Li L; Spendlove I; Morgan J; Durrant LG
    Br J Cancer; 2001 Jan; 84(1):80-6. PubMed ID: 11139317
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Complement regulatory proteins and autoimmunity.
    Kawano M
    Arch Immunol Ther Exp (Warsz); 2000; 48(5):367-72. PubMed ID: 11140463
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Correspondence re: Samowitz et al., Microsatellite instability in sporadic colon cancer is associated with an improved prognosis at the population level. Cancer Epidemiol. Biomark. Prev., 10: 917-923, 2001.
    Dolcetti R; Guidoboni M; Viel A; Boiocchi M
    Cancer Epidemiol Biomarkers Prev; 2002 May; 11(5):499; author reply 499-500. PubMed ID: 12010867
    [No Abstract]   [Full Text] [Related]  

  • 33. New colon cancer test to be available soon.
    Mayo Clin Health Lett; 2014 Oct; 32(10):4. PubMed ID: 26027031
    [No Abstract]   [Full Text] [Related]  

  • 34. Difference in Ulex europaeus agglutinin I-binding activity of decay-accelerating factor detected in the stools of patients with colorectal cancer and ulcerative colitis.
    Okazaki H; Mizuno M; Nasu J; Makidono C; Hiraoka S; Yamamoto K; Okada H; Fujita T; Tsuji T; Shiratori Y
    J Lab Clin Med; 2004 Mar; 143(3):169-74. PubMed ID: 15007307
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Decay-accelerating factor].
    Negoro T; Nakano Y
    Nihon Rinsho; 2010 Jun; 68 Suppl 6():102-4. PubMed ID: 20942012
    [No Abstract]   [Full Text] [Related]  

  • 36. Testing of multiple samples increases the sensitivity of stool decay-accelerating factor test for the detection of colorectal cancer.
    Mizuno M; Mizuno M; Iwagaki N; Nasu J; Okazaki H; Yamamoto K; Okada H; Tsuji T; Fujita T; Shiratori Y
    Am J Gastroenterol; 2003 Nov; 98(11):2550-5. PubMed ID: 14638362
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Increased expression of decay-accelerating factor in patients with colonic neoplasms and the analysis of their feces].
    Mizuno M; Nakagawa M; Uesu A; Nasu J; Inaba T; Matsuoka Y; Kiso T; Fujiki S; Okada H; Fujita S
    Nihon Rinsho Meneki Gakkai Kaishi; 1995 Dec; 18(6):647-50. PubMed ID: 8963772
    [No Abstract]   [Full Text] [Related]  

  • 38. [Immunological tests: Decay-accelerating factor].
    Negoro T; Tobe T
    Nihon Rinsho; 2005 Jul; 63 Suppl 7():98-100. PubMed ID: 16111199
    [No Abstract]   [Full Text] [Related]  

  • 39.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.